Hjem › Akut lungeskade › Pennsylvania
Akut lungeskade kliniske forsøg i Pennsylvania
3 studier for Akut lungeskade søger deltagere på steder i Pennsylvania.
Officiel studietekst (engelsk)
Belumosudil to Block Chronic Lung Allograft Dysfunction (CLAD) in High Risk Lung Transplant Recipients
- University of Pennsylvania (Site #: 71111), Philadelphia
RekruttererFase 2
Alder 12 og opefter · Alle køn · Opdateret 10. aug. 2026 · NCT06476132Lung Injury is One of the Primary Causes of Morbidity and Mortality in Critically Ill Patients. These Patients Will be Monitored for: 1) Immune Cell Activation 2) Blood-based Biomarkers. In Vitro Models Derived From These Samples Will be Treated With Novel Agent PIP-2 to Evaluate Its Efficacy.
- Hospital Of the University of Pennsylvania, Philadelphia
RekruttererObservationsstudie
Alder 21 til 90 · Alle køn · Opdateret 10. jun. 2026 · NCT07125079Clinical Decision Support Tool in PARDS Pilot Study
- Penn State University, Hershey
Rekrutterer
1 Month – 18 Years · Alle køn · Opdateret 14. apr. 2026 · NCT04068012Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.